CA-43-WF29_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (2R)-1-[2-[hydroxy(phosphonooxy)phosphoryl]oxyacetyl]pyrrolidine-2-carboxylic acid, Cholesterol Biosynthesis Inhibitors targeting MVD (Novartis, 44306159)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/44306159
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the CA-43-WF29_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FKBP1A FK506 binding protein 1A, 12kDa 2.43813
GPX4 glutathione peroxidase 4 1.50758
TYMS thymidylate synthetase 1.14568
APRT adenine phosphoribosyltransferase 0.859397
CALU calumenin 0.45034
RPL37 ribosomal protein L37 0.368027
ANAPC11 anaphase promoting complex subunit 11 0.313897
RPL27A ribosomal protein L27a 0.279936
CHRNB2 cholinergic receptor, nicotinic, beta 2 (neuronal) 0.245178
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 0.206604
ESAM endothelial cell adhesion molecule 0.206604

decreased expression

Symbol Name Standardized Value
RPS7 ribosomal protein S7 -0.613338